Chromosomal damage among medical staff occupationally exposed to volatile anesthetics, antineoplastic drugs, and formaldehyde

Scandinavian Journal of Work, Environment and Health

Volumn 39, Issue 6, 2013, Pages 618-630

  Musak, Ludovit ^a   Smerhovsky, Zdenek ^b   Halasova, Erika ^c   Osina, Oto ^a   Letkova, Lucia ^c   Vodickova, Ludmila ^b,d   Polakova, Veronika ^b,d   Buchancova, Janka ^c   Hemminki, Kari ^e   Vodicka, Pavel ^b,d  

^a Martinska Fakultna Nemocnica   (Slovakia)

^b CHARLES UNIVERSITY   (Czech Republic)

^c Faculty of Natural Sciences   (Slovakia)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Anesthesiologist; Chromosomal aberration; Health risk; Hospital staff; Occupational exposure; Oncological department; Pathological department

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; CYTOSTATIC AGENT; FLUOROURACIL; FORMALDEHYDE; IFOSFAMIDE; INHALATION ANESTHETIC AGENT; ISOFLURANE; RITUXIMAB; SEVOFLURANE;

ANESTHETIC; BIOMARKER; CARCINOGEN; CHROMOSOME; FORMALDEHYDE; GENOTOXICITY; HEALTH RISK; HEALTH WORKER; HOSPITAL SECTOR; OCCUPATIONAL EXPOSURE; PATHOLOGY; WORKPLACE;

ADULT; ARTICLE; CHROMATID; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DAMAGE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENOTOXICITY; HOSPITAL DEPARTMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL STAFF; NURSE; OCCUPATIONAL EXPOSURE; OPERATING ROOM; PHYSICIAN; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; ANESTHETICS, INHALATION; ANTINEOPLASTIC AGENTS; CASE-CONTROL STUDIES; CHROMOSOME ABERRATIONS; FEMALE; FORMALDEHYDE; HUMANS; MALE; MIDDLE AGED; MUTAGENS; OCCUPATIONAL EXPOSURE; SLOVAKIA; VOLATILIZATION;

EID: 84887078561     PISSN: 03553140     EISSN: 1795990X     Source Type: Journal    
DOI: 10.5271/sjweh.3358     Document Type: Article

References (54)

1. Cavallo D, Ursini CL, Omodeo-Sale E, Iavicoli S. Micronucleus induction and FISH analysis in buccal cells and lymphocytes of nurses administering antineoplastic drugs. Mutat Res. 2007 Mar 30;628(1):11-8. http://dx.doi.org/10.1016/j.mrgentox.2006.10.014.
2. Rekhadevi PV, Sailaja N, Chandrasekhar M, Mahboob M, Rahman MF, Grover P. Genotoxicity assessment in oncology nurses handling anti-neoplastic drugs. Mutagenesis. 2007 Nov;22(6):395-401. http://dx.doi.org/10.1093/mutage/gem032.
3. Schmid O, Speit G. Genotoxic effects induced by formaldehyde in human blood and implications for the interpretation of biomonitoring studies. Mutagenesis. 2007 Jan;22(1):69-74. http://dx.doi.org/10.1093/mutage/gel053.
4. Neuss S, Speit G. Further characterization of the genotoxicity of formaldehyde in vitro by the sister chromatid exchange test and co-cultivation experiments. Mutagenesis. 2008 Sep;23(5):355-7. http://dx.doi.org/10.1093/mutage/gen025.
5. Wiesner G, Schiewe-Langgartner F, Lindner R, Gruber M. Increased formation of sister chromatid exchanges, but not of micronuclei, in anaesthetists exposed to low levels of sevoflurane. Anaesthesia. 2008 Aug;63(8):861-4. http://dx.doi.org/10.1111/j.1365-2044.2008.05498.x.
6. Jakab MG, Klupp T, Besenyei K, Biro A, Major J, Tompa A. Formaldehyde-induced chromosomal aberrations and apoptosis in peripheral blood lymphocytes of personnel working in pathology departments. Mutat Res. 2010 Apr 30;698(1-2):11-7. http://dx.doi.org/10.1016/j.mrgentox.2010.02.015.
7. Gulten T, Evke E, Ercan I, Evrensel T, Kurt E, Manavoglu O. Lack of genotoxicity in medical oncology nurses handling antineoplastic drugs: effect of work environment and protective equipment. Work. 2011 Jan;39(4):485-9.
8. Costa S, Pina C, Coelho P, Costa C, Silva S, Porto B, et al. Occupational exposure to formaldehyde: genotoxic risk evaluation by comet assay and micronucleus test using human peripheral lymphocytes. J Toxicol Environ Health A. 2011;74(15-16):1040-51. http://dx.doi.org/10.1080/15287394.2011.582293.
9. Ladeira C, Viegas S, Carolino E, Prista J, Gomes MC, Brito M. Genotoxicity biomarkers in occupational exposure to formaldehyde--the case of histopathology laboratories. Mutat Res. 2011 Mar 18;721(1):15-20. http://dx.doi.org/10.1016/j.mrgentox.2010.11.015.
10. Santovito A, Schiliro T, Castellano S, Cervella P, Bigatti MP, Gilli G, et al. Combined analysis of chromosomal aberrations and glutathione S-transferase M1 and T1 polymorphisms in pathologists occupationally exposed to formaldehyde. Arch Toxicol. 2011 Oct;85(10):1295-302. http://dx.doi.org/10.1007/s00204-011-0668-3.
11. Jaloszynski P, Kujawski M, Wasowicz M, Szulc R, Szyfter K. Genotoxicity of inhalation anesthetics halothane and isoflurane in human lymphocytes studied in vitro using the comet assay. Mutat Res. 1999 Feb 19;439(2):199-206. http://dx.doi.org/10.1016/S1383-5718(98)00195-8.
12. Karpinski TM, Kostrzewska-Poczekaj M, Stachecki I, Mikstacki A, Szyfter K. Genotoxicity of the volatile anaesthetic desflurane in human lymphocytes in vitro, established by comet assay. J Appl Genet. 2005;46(3):319-24.
13. International Agency for Research on Cancer (IARC). Formaldehyde, 2-butoxyethanol and 1-tert-butoxypropan-2-ol. IARC Monogr Eval Carcinog Risks Hum. 2006;88:1-478.
14. Rozgaj R, Kasuba V, Brozovic G, Jazbec A. Genotoxic effects of anaesthetics in operating theatre personnel evaluated by the comet assay and micronucleus test. Int J Hyg Environ Health,2009 Jan;212(1):11-7. http://dx.doi.org/10.1016/j.ijheh.2007.09.001.
15. Lewinska D, Stepnik M, Krajewski W, Arkusz J, Stanczyk M, Wronska-Nofer T. Increased incidence of micronuclei assessed with the micronucleus assay and the fluorescence in situ hybridization (FISH) technique in peripheral blood lymphocytes of nurses exposed to nitrous oxide. Mutat Res. 2005 Mar 7;581(1-2):1-9. http://dx.doi.org/10.1016/j.mrgentox.2004.10.018.
16. Braz MG, Mazoti MA, Giacobino J, Braz LG, Golim Mde A, Ferrasi AC, et al. Genotoxicity, cytotoxicity and gene expression in patients undergoing elective surgery under isoflurane anaesthesia. Mutagenesis. 2011 May;26(3):415-20. http://dx.doi.org/10.1093/mutage/geq109.
17. Wronska-Nofer T, Nofer JR, Jajte J, Dziubaltowska E, Szymczak W, Krajewski W, et al. Oxidative DNA damage and oxidative stress in subjects occupationally exposed to nitrous oxide (N(2)O). Mutat Res. 2012 Mar 1;731(1-2):58-63. http://dx.doi.org/10.1016/j.mrfmmm.2011.10.010.
18. Braz MG, Braz LG, Barbosa BS, Giacobino J, Orosz JE, Salvadori DM, et al. DNA damage in patients who underwent minimally invasive surgery under inhalation or intravenous anesthesia. Mutat Res. 2011 Dec 24;726(2):251-4. http://dx.doi.org/10.1016/j.mrgentox.2011.09.007.
19. Gabano E, Ravera M, Osella D. The drug targeting and delivery approach applied to pt-antitumour complexes. A coordination point of view. Curr Med Chem. 2009;16(34):4544-80. http://dx.doi.org/10.2174/092986709789760661.
20. International Agency for Research on Cancer (IARC). Agents classified by the IARC Monographs. IARC Monogr Eval Carcinog Risks Hum. 2012;vol:1-104.
21. Musak L, Vodicka P, Klimentova G, Soucek P, Hanova M, Mikulkova R, et al. Chromosomal damage and polymorphisms of DNA repair genes XRCC1 and XRCC3 in workers exposed to cytostatics. Neuro Endocrinol Lett. 2006 Dec;27 Suppl 2:57-60.
22. Tompa A, Magyar B, Toth F, Biro A, Fodor Z, Jakab M, et al. [The state of health of oncology nurses characterized by genetic and immunotoxicologic biomarkers]. Magy Onkol. 2006;50(2):153-61.
23. Testa A, Giachelia M, Palma S, Appolloni M, Padua L, Tranfo G, et al. Occupational exposure to antineoplastic agents induces a high level of chromosome damage. Lack of an effect of GST polymorphisms. Toxicol Appl Pharmacol. 2007 Aug 15;223(1):46-55. http://dx.doi.org/10.1016/j.taap.2007.05.006.
24. Cornetta T, Padua L, Testa A, Ievoli E, Festa F, Tranfo G, et al. Molecular biomonitoring of a population of nurses handling antineoplastic drugs. Mutat Res. 2008 Feb 1;638(1-2):75-82. http://dx.doi.org/10.1016/j.mrfmmm.2007.08.017.
25. Kopjar N, Garaj-Vrhovac V, Kasuba V, Rozgaj R, Ramic S, Pavlica V, et al. Assessment of genotoxic risks in Croatian health care workers occupationally exposed to cytotoxic drugs: a multi-biomarker approach. Int J Hyg Environ Health. 2009 Jul;212(4):414-31. http://dx.doi.org/10.1016/j.ijheh.2008.10.001.
26. Boughattas AB, Bouraoui S, Debbabi F, El Ghazel H, Saad A, Mrizak N. Évaluation du risque génotoxique chez les infirmiers manipulant les cytostatiques [Genotoxic risk assessment of nurses handling antineoplastic drugs]. Ann Biol Clin (Paris.) 2010 Sep-Oct;68(5):545-53.
27. Zeller J, Neuss S, Mueller JU, Kuhner S, Holzmann K, Hogel J, et al. Assessment of genotoxic effects and changes in gene expression in humans exposed to formaldehyde by inhalation under controlled conditions. Mutagenesis. 2011 Jul;26(4):555-61. http://dx.doi.org/10.1093/mutage/ger016.
28. Speit G, Ladeira C, Linsenmeyer R, Schutz P, Hogel J. Re-evaluation of a reported increased micronucleus frequency in lymphocytes of workers occupationally exposed to formaldehyde. Mutat Res. 2012 May 15;744(2):161-6. http://dx.doi.org/10.1016/j.mrgentox.2012.02.009.
29. US Department of Health and Human Services, Public Health Service. National Toxicology Program. Final Report on Carcinogens Background Document for Formaldehyde. Rep Carcinog Backgr Doc. 2010 Jan;(10-5981): i-512.
30. th Report on Carcinogens. Rep Carcinog. 2011;12:iii-499.
31. Hagmar L, Stromberg U, Bonassi S, Hansteen IL, Knudsen LE, Lindholm C, et al. Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts. Cancer Res. 2004 Mar 15;64(6):2258-63. http://dx.doi.org/10.1158/0008-5472.CAN-03-3360.
32. Bonassi S, Norppa H, Ceppi M, Stromberg U, Vermeulen R, Znaor A, et al. Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22 358 subjects in 11 countries. Carcinogenesis. 2008 Jun;29(6):1178-83. http://dx.doi.org/10.1093/carcin/bgn075.
33. Vodicka P, Polivkova Z, Sytarova S, Demova H, Kucerova M, Vodickova L, et al. Chromosomal damage in peripheral blood lymphocytes of newly diagnosed cancer patients and healthy controls. Carcinogenesis. 2010 Jul;31(7):1238-41. http://dx.doi.org/10.1093/carcin/bgq056.
34. Musak L, Soucek P, Vodickova L, Naccarati A, Halasova E, Polakova V, et al. Chromosomal aberrations in tire plant workers and interaction with polymorphisms of biotransformation and DNA repair genes. Mutat Res. 2008 May 10;641(1-2):36-42. http://dx.doi.org/10.1016/j.mrfmmm.2008.02.007.
35. Albertini RJ, Anderson D, Douglas GR, Hagmar L, Hemminki K, Merlo F, et al. IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. International Programme on Chemical Safety. Mutat Res. 2000 Aug;463(2):111-72. http://dx.doi.org/10.1016/S1383-5742(00)00049-1.
36. Norppa H, Bonassi S, Hansteen IL, Hagmar L, Stromberg U, Rossner P, et al. Chromosomal aberrations and SCEs as biomarkers of cancer risk. Mutat Res. 2006 Aug 30;600(1-2):37-45. http://dx.doi.org/10.1016/j.mrfmmm.2006.05.030.
37. Sram RJ, Rossner P, Smerhovsky Z. Cytogenetic analysis and occupational health in the Czech Republic. Mutat Res. 2004 Jan;566(1):21-48. http://dx.doi.org/10.1016/S1383-5742(03)00034-6.
38. Rozgaj R, Kasuba V, Peric M. Chromosome aberrations in operating room personnel. Am J Ind Med. 1999 Jun;35(6):642-6. http://dx.doi.org/10.1002/(SICI)1097-0274(199906)35:6<642::AID-AJIM11>3.0.CO;2-N.
39. Rozgaj R, Kasuba V, Jazbec A. Preliminary study of cytogenetic damage in personnel exposed to anesthetic gases. Mutagenesis. 2001 Mar;16(2):139-43. http://dx.doi.org/10.1093/mutage/16.2.139.
40. Natarajan AT. Chromosome aberrations: past, present and future. Mutat Res. 2002 Jul 25;504(1-2):3-16. http://dx.doi.org/10.1016/S0027-5107(02)00075-1.
41. Wiesner G, Harth M, Hoerauf K, Szulc R, Jurczyk W, Sobczynski P, et al. Occupational exposure to inhaled anaesthetics: a follow-up study on anaesthetists of an eastern European university hospital. Acta Anaesthesiol Scand. 2000 Aug;44(7):804-6. http://dx.doi.org/10.1034/j.1399-6576.2000.440706.x.
42. Wiesner G, Hoerauf K, Schroegendorfer K, Sobczynski P, Harth M, Ruediger HW. High-level, but not low-level, occupational exposure to inhaled anesthetics is associated with genotoxicity in the micronucleus assay. Anesth Analg. 2001 Jan;92(1):118-22. http://dx.doi.org/10.1097/00000539-200101000-00023.
43. Vodicka P, Kumar R, Stetina R, Sanyal S, Soucek P, Haufroid V, et al. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis. 2004;25(5):757-63. http://dx.doi.org/10.1093/carcin/bgh064.
44. Hagmar L, Stromberg U, Tinnerberg H, Mikoczy Z. Epidemiological evaluation of cytogenetic biomarkers as potential surrogate end-points for cancer. IARC Sci Publ. 2004;(157):207-15.
45. Rossner P, Boffetta P, Ceppi M, Bonassi S, Smerhovsky Z, Landa K, et al. Chromosomal aberrations in lymphocytes of healthy subjects and risk of cancer. Environ Health Perspect. 2005 May;113(5):517-20. http://dx.doi.org/10.1289/ehp.6925.
46. Burgaz S, Karahalil B, Canhi Z, Terzioglu F, Ancel G, Anzion RB, et al. Assessment of genotoxic damage in nurses occupationally exposed to antineoplastics by the analysis of chromosomal aberrations. Hum Exp Toxicol. 2002 Mar;21(3):129-35. http://dx.doi.org/10.1191/0960327102ht230oa.
47. Bilban M, Jakopin CB, Ogrinc D. Cytogenetic tests performed on operating room personnel (the use of anaesthetic gases). Int Arch Occup Environ Health. 2005 Feb;78(1):60-4. http://dx.doi.org/10.1007/s00420-004-0579-1.
48. Rombaldi F, Cassini C, Salvador M, Saffi J, Erdtmann B. Occupational risk assessment of genotoxicity and oxidative stress in workers handling anti-neoplastic drugs during a working week. Mutagenesis. 2009 Mar;24(2):143-8. http://dx.doi.org/10.1093/mutage/gen060.
49. Fransman W, Vermeulen R, Kromhout H. Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities. Int Arch Occup Environ Health. 2005 Jun;78(5):403-12. http://dx.doi.org/10.1007/s00420-004-0595-1.
50. Fransman W, Roeleveld N, Peelen S, de Kort W, Kromhout H, Heederik D. Nurses with dermal exposure to antineoplastic drugs: reproductive outcomes. Epidemiology. 2007 Jan;18(1):112-9. http://dx.doi.org/10.1097/01.ede.0000246827.44093.c1.
51. Connor TH. Hazardous anticancer drugs in health care: environmental exposure assessment. Ann N Y Acad Sci. 2006 Sep;1076:615-23. http://dx.doi.org/10.1196/annals.1371.021.
52. Moretti M, Bonfiglioli R, Feretti D, Pavanello S, Mussi F, Grollino MG, et al. A study protocol for the evaluation of occupational mutagenic/carcinogenic risks in subjects exposed to antineoplastic drugs: a multicentric project. BMC Public Health. 2011;11:195. http://dx.doi.org/10.1186/1471-2458-11-195.
53. Prokes B. Kretanje nivoa "izgubljenog" halotana u operacionim salama klinike za ginekologiju i akuserstvo-preliminarni rezultati. [Levels of "waste" halothane in operating rooms at gynecologic and obstetrical clinics--preliminary results]. Med Pregl.1998 Nov-Dec;51(11-12):532-6.
54. Slyskova J, Korenkova V, Collins AR, Prochazka P, Vodickova L, Svec J, et al. Functional, Genetic, and Epigenetic Aspects of Base and Nucleotide Excision Repair in Colorectal Carcinomas. Clin Cancer Res. 2012 Nov 1;18(21):5878-87. http://dx.doi.org/10.1158/1078-0432.CCR-12-1380.